Publications

Low Circulating Natural Killer Cell Counts are Associated With Severe Disease in Patients With Common Variable Immunodeficiency

Ebbo M, Gérard L, Carpentier S, Vély F, Cypowyj S, Farnarier C, Vince N, Malphettes M, Fieschi C, Oksenhendler E, Schleinitz N, Vivier E; DEFI Study Group.EBioMedicine, 2016 , 6:222-30, PMID: 27211564

Innate Lymphoid Cells: new actors of immunity

Cypowyj S, Vivier É. Bull Acad Natl Med, 2016 , 200, 561-573, PMID: 28644604

NK Cell-Specific Gata3 Ablation Identifies the Maturation Program Required for Bone Marrow Exit and Control of Proliferation

Ali AK., Oh JS, Vivier E, Busslinger M, Lee SH.J Immunol., 2016 , 196(4):1753-67, PMID: 26773150

NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions

Ludigs K, Jandus C, Utzschneider DT, Staehli F, Bessoles S, Dang AT, Rota G, Castro W, Zehn D, Vivier E, Held W, Romero P, Guarda G.Nat Commun., 2016 , 7:10554, PMID: 26861112

Editorial overview: Innate immunity.

Vivier E, Medzhitov R.Curr Opin Immunol., 2016 , 38:v-vii, PMID: 26739338

Innate lymphoid cells: parallel checkpoints and coordinate interactions with T cells

Huntington ND, Carpentier S, Vivier E, Belz GT.Curr Opin Immunol., 2016 , 38:86-93, PMID: 26736074

Innate myeloid cells under the control of adaptive immunity: the example of mast cells and basophils

Daëron M.Curr Opin Immunol., 2016 , 38:101-8, PMID: 26745401

Cutting Edge: Eomesodermin Is Sufficient To Direct Type 1 Innate Lymphocyte Development into the Conventional NK Lineage

Pikovskaya O, Chaix J, Rothman NJ, Collins A, Chen YH, Scipioni AM, Vivier E, Reiner SL.J Immunol., 2016 , 196(4):1449-54, PMID: 26792802

The Helix-Loop-Helix Protein ID2 Governs NK Cell Fate by Tuning Their Sensitivity to Interleukin-15

Delconte RB, Shi W, Sathe P, Ushiki T, Seillet C, Minnich M, Kolesnik TB, Rankin LC, Mielke LA, Zhang JG, Busslinger M, Smyth MJ, Hutchinson DS, Nutt SL, Nicholson SE, Alexander WS, Corcoran LM, Vivier E, Belz GT, Carotta S, Huntington ND.Immunity, 2016 , 44(1):103-15, PMID: 26795246

Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC

Benjamin Besse, Mélinda Charrier, Valérie Lapierre, Eric Dansin, Olivier Lantz, David Planchard, Thierry Le Chevalier, Alain Livartoski, Fabrice Barlesi, Agnès Laplanche, Stéphanie Ploix, Nadège Vimond, Isabelle Peguillet, Clotilde Théry, Ludovic Lacroix, Inka Zoernig, Kavita Dhodapkar, Madhav Dhodapkar, Sophie Viaud, Jean-Charles Soria, Katrin S Reiners, Elke Pogge von Strandmann, Frédéric Vély, Sylvie Rusakiewicz , Alexander Eggermont , Jonathan M Pitt, Laurence Zitvogel , Nathalie Chaput ONCOIMMUNOLOGY, 2016 , 5, PMID: 27141373